[1]
U. Azizov and N. Kholiyarov, “DISADVANTAGES OF PHARMACEUTICAL ACTIVITIES: IMPACT ON PUBLIC HEALTH, ECONOMY AND SECURITY”, SID, vol. 3, no. 4, pp. 134–143, Sep. 2020.